Skip to main content

You make this possible. Support our independent, nonprofit newsroom today.

Give Now

Novavax Vaccine Appears 86% Effective Against U.K's COVID-19 Variant

Vaccine maker Novavax is waiting for its COVID-19 vaccine to be approved in the U.K., and is hopeful that U.S. approval will follow. NPR's Steve Inskeep speaks to Novavax CEO Stanley Erck.

[Copyright 2021 NPR]

Why you can trust KUOW